# Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

> **NCT00090779** · PHASE2 · TERMINATED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 130 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Emtricitabine/ tenofovir disoproxil fumarate
- **DRUG:** Lopinavir/Ritonavir

## Key facts

- **NCT ID:** NCT00090779
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2009-07
- **Final completion:** 2011-05
- **Target enrollment:** 130 (ACTUAL)
- **Why stopped:** The DSMB concluded that the findings regarding the primary analysis would persist and that no additional study goals would be achieved by continuing the study.
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090779, "Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00090779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*